Literature DB >> 16132817

The central roles of telomeres and subtelomeres in antigenic variation in African trypanosomes.

David Horn1, J David Barry.   

Abstract

Telomeres and subtelomeres are important to the virulence of a number of pathogens, as they harbour large diverse gene families associated with the maintenance of infection. Evasion of immunity by African trypanosomes involves the differential expression of variant surface glycoproteins (VSGs), which are encoded by a family of >1500 genes and pseudogenes. This silent archive is located subtelomerically and is activated by gene conversion into specialized transcription units, which themselves are subject to silencing by allelic exclusion. Current research addresses the role of telomeres in the conversion and silencing mechanisms and in the diversification of the VSG archive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132817     DOI: 10.1007/s10577-005-0991-8

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  66 in total

1.  A pol I transcriptional body associated with VSG mono-allelic expression in Trypanosoma brucei.

Authors:  M Navarro; K Gull
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  A structural and transcription pattern for variant surface glycoprotein gene expression sites used in metacyclic stage Trypanosoma brucei.

Authors:  S V Graham; S Terry; J D Barry
Journal:  Mol Biochem Parasitol       Date:  1999-10-15       Impact factor: 1.759

3.  A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei.

Authors:  José A García-Salcedo; Purificación Gijón; Derek P Nolan; Patricia Tebabi; Etienne Pays
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

4.  A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length.

Authors:  Syed H Askree; Tal Yehuda; Sarit Smolikov; Raya Gurevich; Joshua Hawk; Carrie Coker; Anat Krauskopf; Martin Kupiec; Michael J McEachern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

5.  Gene conversions mediating antigenic variation in Trypanosoma brucei can occur in variant surface glycoprotein expression sites lacking 70-base-pair repeat sequences.

Authors:  R McCulloch; G Rudenko; P Borst
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  Organization of telomeric and sub-telomeric regions of chromosomes from the protozoan parasite Trypanosoma cruzi.

Authors:  M A Chiurillo; I Cano; J F Da Silveira; J L Ramirez
Journal:  Mol Biochem Parasitol       Date:  1999-05-25       Impact factor: 1.759

7.  Telomere shortening and cell cycle arrest in Trypanosoma brucei expressing human telomeric repeat factor TRF1.

Authors:  J L Muñoz-Jordán; G A Cross
Journal:  Mol Biochem Parasitol       Date:  2001-05       Impact factor: 1.759

8.  A variant histone H3 is enriched at telomeres in Trypanosoma brucei.

Authors:  Joanna E Lowell; George A M Cross
Journal:  J Cell Sci       Date:  2004-11-02       Impact factor: 5.285

Review 9.  The molecular control of antigenic variation in Trypanosoma brucei.

Authors:  David Horn
Journal:  Curr Mol Med       Date:  2004-09       Impact factor: 2.222

10.  Identification of a telomeric DNA sequence in Trypanosoma brucei.

Authors:  E H Blackburn; P B Challoner
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

View more
  34 in total

1.  CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei.

Authors:  Michael D Scahill; Irena Pastar; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2007-10-06       Impact factor: 1.759

2.  Mild Telomere Dysfunction as a Force for Altering the Adaptive Potential of Subtelomeric Genes.

Authors:  Jennifer M O Mason; Michael J McEachern
Journal:  Genetics       Date:  2017-12-14       Impact factor: 4.562

3.  Characterization of a Trypanosoma brucei Alkb homolog capable of repairing alkylated DNA.

Authors:  Jana M Simmons; Donna J Koslowsky; Robert P Hausinger
Journal:  Exp Parasitol       Date:  2012-03-20       Impact factor: 2.011

4.  Fe(II)/alpha-ketoglutarate hydroxylases involved in nucleobase, nucleoside, nucleotide, and chromatin metabolism.

Authors:  Jana M Simmons; Tina A Müller; Robert P Hausinger
Journal:  Dalton Trans       Date:  2008-06-27       Impact factor: 4.390

5.  TOPO3alpha influences antigenic variation by monitoring expression-site-associated VSG switching in Trypanosoma brucei.

Authors:  Hee-Sook Kim; George A M Cross
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

6.  Transitions between the Arabidopsis-type and the human-type telomere sequence in green algae (clade Caudivolvoxa, Chlamydomonadales).

Authors:  Jana Fulnečková; Tereza Ševčíková; Alena Lukešová; Eva Sýkorová
Journal:  Chromosoma       Date:  2015-11-23       Impact factor: 4.316

7.  Streamlined architecture and glycosylphosphatidylinositol-dependent trafficking in the early secretory pathway of African trypanosomes.

Authors:  Elitza S Sevova; James D Bangs
Journal:  Mol Biol Cell       Date:  2009-09-16       Impact factor: 4.138

8.  RAP1 is essential for silencing telomeric variant surface glycoprotein genes in Trypanosoma brucei.

Authors:  Xiaofeng Yang; Luisa M Figueiredo; Amin Espinal; Eiji Okubo; Bibo Li
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

9.  Blocking variant surface glycoprotein synthesis in Trypanosoma brucei triggers a general arrest in translation initiation.

Authors:  Terry K Smith; Nadina Vasileva; Eva Gluenz; Stephen Terry; Neil Portman; Susanne Kramer; Mark Carrington; Shulamit Michaeli; Keith Gull; Gloria Rudenko
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

Review 10.  DNA breaks as triggers for antigenic variation in African trypanosomes.

Authors:  Sam Alsford; David Horn; Lucy Glover
Journal:  Genome Biol       Date:  2009-06-08       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.